Asensus Surgical Inc (FRA:2TX)
€ 0.305 0.0474 (18.4%) Market Cap: 85.31 Mil Enterprise Value: 96.67 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q4 2023 Asensus Surgical Inc Earnings Call Transcript

Mar 21, 2024 / 08:30PM GMT
Release Date Price: €0.256 (+3.23%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Essentis surgical Inc. fourth quarter and full year 2023 financial and operating results conference call.

At this time, all lines are in listen only mode. Following the presentation, we will conduct a question and answer session. If at any time during this call you require immediate assistance, please press star zero for the operator. This call is being recorded on Thursday, March 21st, 2024.

I would now like to turn the conference over to Mark Klausner from Westwicke Partners. Please go ahead.

Mark Klausner
Westwicke Partners, LLC - IR

Good afternoon, everyone, and thank you for joining us for the Essentis surgical Fourth Quarter and Full Year 2023 business and financial update conference call.

On the call with me today are Anthony Fernando, President and Chief Executive Officer, and Jim East, Rand per cab, Chief Financial Officer.

Before we begin, I would like to caution listeners that certain information discussed by management during this conference call,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot